APNHY Live-Signale | Maximieren Sie Profite mit Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 Mai 2024 @ 15:37):

Stats
Tagesvolumen	109.00
Durchschnittsvolumen	190.00
Marktkapitalisierung	5.55B
Last Dividend	$0.184 ( 2023-09-21 )
Next Dividend	$0 ( N/A )
P/E	21.53
ATR14	$0 (0.00%)

Aspen Pharmacare Holdings Korrelation

10 Am meisten positiv korreliert

10 Am meisten negativ korreliert

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Aspen Pharmacare Holdings Finanzdaten

Annual	2023
Umsatz:	$2.29B
Bruttogewinn:	$1.02B (44.59 %)
EPS:	$0.660

FY	2023
Umsatz:	$2.29B
Bruttogewinn:	$1.02B (44.59 %)
EPS:	$0.660

FY	2022
Umsatz:	$2.54B
Bruttogewinn:	$1.15B (45.40 %)
EPS:	$0.940

FY	2021
Umsatz:	$37.77B
Bruttogewinn:	$17.76B (47.03 %)
EPS:	$10.53

Financial Reports:

No articles found.

Aspen Pharmacare Holdings Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.133 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0.184 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Aspen Pharmacare Holdings Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 5.17 - Stable (3.40%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.101	2010-10-06
Last Dividend	$0.184	2023-09-21
Next Dividend	$0	N/A
Payout Date	2023-10-11
Next Payout Date	N/A
# dividends	12	--
Total Paid Out	$2.03	--
Avg. Dividend % Per Year	0.00%	--
Score	2.69	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	5.17
Div. Directional Score	7.90	--

Next Divdend (Est)
(2024-08-07)

$0.190 Estimate 3.02 %

Dividend Stability

0.24 Very Poor

Dividend Score

2.69

Pay Frequency

Sporadic

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for OTC

Symbol	Title	Last dividend	Frequency	Yearly Dividend
TXHPF	Ex Dividend Knight	2023-12-28	Semi-Annually	0.00%
JARLF	Ex Dividend Knight	2023-08-17	Semi-Annually	0.00%
BDVSY	Ex Dividend Junior	2023-09-28	Annually	0.00%
RCBC	Ex Dividend Junior	2023-07-31	Quarterly	0.00%
ENGGY	Ex Dividend Knight	2023-07-03	Semi-Annually	0.00%
WBHC	Ex Dividend Junior	2023-06-29	Sporadic	0.00%
LDSCY	Ex Dividend Junior	2023-08-24	Quarterly	0.00%
CCFN	Ex Dividend Knight	2023-08-14	Quarterly	0.00%
SGAPY	Ex Dividend Knight	2023-08-02	Semi-Annually	0.00%
FRFC	Ex Dividend Knight	2023-09-06	Quarterly	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.114	1.500	7.72	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0349	1.200	8.84	10.00	[0 - 0.3]
returnOnEquityTTM	0.0743	1.500	-0.285	-0.428	[0.1 - 1]
payoutRatioTTM	0.315	-1.000	6.85	-6.85	[0 - 1]
currentRatioTTM	1.918	0.800	5.41	4.33	[1 - 3]
quickRatioTTM	1.053	0.800	8.51	6.81	[0.8 - 2.5]
cashRatioTTM	0.505	1.500	8.30	10.00	[0.2 - 2]
debtRatioTTM	0.259	-1.500	5.68	-8.52	[0 - 0.6]
interestCoverageTTM	88.18	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	14.11	2.00	5.30	10.00	[0 - 30]
freeCashFlowPerShareTTM	7.62	2.00	6.19	10.00	[0 - 20]
debtEquityRatioTTM	0.422	-1.500	8.31	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.450	1.000	5.83	5.83	[0.2 - 0.8]
operatingProfitMarginTTM	0.200	1.000	8.00	8.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.174	1.000	-0.146	-0.146	[0.2 - 2]
assetTurnoverTTM	0.307	0.800	-1.290	-1.032	[0.5 - 2]
Total Score				10.62

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	19.65	1.000	8.12	0	[1 - 100]
returnOnEquityTTM	0.0743	2.50	-0.183	-0.428	[0.1 - 1.5]
freeCashFlowPerShareTTM	7.62	2.00	7.46	10.00	[0 - 30]
dividendYielPercentageTTM	0.00450	1.500	9.89	0	[0 - 0.4]
operatingCashFlowPerShareTTM	14.11	2.00	5.30	10.00	[0 - 30]
payoutRatioTTM	0.315	1.500	6.85	-6.85	[0 - 1]
pegRatioTTM	0.0215	1.500	-3.19	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.147	1.000	8.83	0	[0.1 - 0.5]
Total Score				5.17

Aspen Pharmacare Holdings

Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand. It also offers branded consumer, prescription, and over-the-counter products under the regional brands, such as Circadin, Foxair, Maltofer, Mybulen, and Zyloric for various types of anesthetic comprises sleeping aid, respiratory, iron supplement, analgesic, and uric acid production inhibitor. In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products to third-party customers. The company was founded in 1850 and is headquartered in Durban, South Africa.